YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DR26FQST6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,568
Award facts
- Contract value 100% obligated
- $5,567.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,567.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Yellow Fever vaccine (YF-VAX) 1-dose vials. The delivery order, issued on November 14, 2025, with an ultimate completion date of December 8, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors. The underlying IDC, designated SPE2DR and awarded November 13, 2025, carries a ceiling value of $499,999,999 with completion through December 31, 2036.
Under the PPV-G GEN V program, DMS Pharmaceutical Group is authorized to supply a comprehensive range of pharmaceutical products—including branded and generic prescription drugs, biologics, vaccines, and medical consumables—to support Department of Defense military healthcare facilities worldwide. The vendor's established capability is demonstrated through substantial recent contracting activity with DLA's Medical Supply Chain division, with delivery orders ranging from under $100 to over $115,000. This delivery order for Yellow Fever vaccine represents routine fulfillment of the military medical system's recurring immunization supply requirements under the broader pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DR26FQST6?
SPE2DR26FQST6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FQST6 worth?
The government has obligated $5,568 on SPE2DR26FQST6.
Is contract SPE2DR26FQST6 an order under another contract?
Yes. SPE2DR26FQST6 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQST6 competed?
The extent of competition for SPE2DR26FQST6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award